Market Insights Health Pharmacies OTC Products

Cold & Cough Remedies (Pharmacies) - Netherlands

Netherlands

Revenue in the Cold & Cough Remedies market is projected to reach €122.20m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 3.12%, resulting in a market volume of €138.20m by 2028.
In global comparison, most revenue will be generated in China (€7,257.00m in 2024).
In relation to total population figures, per person revenues of €6.92 are generated in 2024.

Key regions: United Kingdom, South Korea, Europe, Japan, Germany

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Cold & Cough Remedies (Pharmacies) market in Netherlands has been experiencing steady growth in recent years.

Customer preferences: Customers in Netherlands have shown a strong preference for over-the-counter cold and cough remedies available at pharmacies. This preference can be attributed to the convenience and accessibility of these products, as well as the trust that customers have in the expertise of pharmacists.

Trends in the market: One of the key trends in the Cold & Cough Remedies (Pharmacies) market in Netherlands is the increasing demand for natural and herbal remedies. Customers are becoming more conscious about the ingredients used in these products and are opting for those that are perceived to be more natural and less chemically based. This trend is in line with the overall shift towards healthier and more sustainable lifestyles observed globally. Another trend in the market is the growing popularity of combination products that address multiple symptoms of cold and cough. Customers are looking for convenient solutions that provide relief from various symptoms, such as nasal congestion, sore throat, and cough, in a single product. This trend reflects the increasing demand for products that offer comprehensive relief and convenience to customers.

Local special circumstances: The Netherlands has a well-developed healthcare system that provides easy access to pharmacies and healthcare professionals. This accessibility has contributed to the growth of the Cold & Cough Remedies (Pharmacies) market in the country. Customers can easily seek advice from pharmacists and purchase the necessary remedies without the need for a prescription. Additionally, the Dutch population has a high level of health consciousness and is proactive in managing their health. This has created a favorable environment for the growth of the Cold & Cough Remedies (Pharmacies) market, as customers are more likely to seek remedies at the early stages of a cold or cough.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies (Pharmacies) market in Netherlands can also be attributed to the overall economic stability of the country. The Netherlands has a high standard of living and a strong healthcare infrastructure, which enables customers to afford and access healthcare products. Furthermore, the aging population in the Netherlands has contributed to the growth of the market. Older individuals are more susceptible to cold and cough, and therefore have a higher demand for remedies. The aging population in the country has been increasing steadily, creating a larger customer base for the Cold & Cough Remedies (Pharmacies) market. In conclusion, the Cold & Cough Remedies (Pharmacies) market in Netherlands is developing due to customer preferences for over-the-counter remedies, the increasing demand for natural and combination products, the accessibility of pharmacies, the health-consciousness of the population, and the underlying macroeconomic factors such as economic stability and an aging population.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.